Jump to content

Harrison Stafford

Legacy Members
  • Posts

    2854
  • Joined

  • Last visited

Everything posted by Harrison Stafford

  1. His highlights give off a Patrick Mahomes vibe. Me gusta.
  2. Been watching the NBA & college hoops since the mid 60’s and have never seen a big man who can pass like Jokic. Bill Walton (before all the injuries) was the best passing center I’d seen, but Jokic blows him away. His court vision/awareness is just ridiculous.
  3. My lottery tickets are IBRX, UUUU, RVPH, AMYZF, EOSE, and GERN. To the moon, Alice!
  4. It’s a Christmas miracle!
  5. I think Hop’s willing to take less for a chance at a ring and that sure as hell ain’t happening with Dallas or Atlanta.
  6. Yep. Hop goes to Buffalo or KC.
  7. Filled the last 3000 share order at 6.60 bringing the total position to 15,000 shares of RVPH. Es todo.
  8. It’s not just a miracle. It’s a Christmas miracle
  9. Josh Fields is on his way to becoming the answer to a sports trivia question.
  10. If only Alvarez could hit.
  11. Filled the 3000 share RVPH order at 7.03. Now have 12,000 shares of RVPH. Have one GTC buy left at 6.60. Wouldn’t bother me at all if that order never fills.
  12. Perhaps, people are realizing the problem isn’t with the drug.
  13. Just hope RVPH isn’t using IBRX’s 3rd party manufacturers.
  14. RVPH order filled at 7.60 for 3000 shares. Now own 9000 shares of RVPH. Placed GTC orders for 3000 more at 7.03 and another 3000 at 6.60.
  15. RVPH has one compound they’re actively working on. IBRX has 16 or 17 trials ongoing with several of them at late stage. The FDA didn’t have issues with IBRX’s bladder cancer drug or the results. I think IBRX’s CEO, Patrick Soon-Shiong, has a meeting w/FDA to find out exactly what needs to happen with the manufacturing facilities. Then, he has to decide how much money and time that will take, so he can reapply for permission to market the drug. Then, he’ll decide whether to foot the bill himself or partner w/big pharma before the drug gets approved. Of course, he wants to partner >after< the bladder drug is approved to get full value. My take is he’ll foot the bill himself (he’s already pumped $700 million into the company), wait for FDA approval, and, then, partner w/big pharma. If something was seriously flawed with IBRX’s drug, the stock would be trading under a dollar…instead of where it was two weeks ago. Finally, the real losers today are the patients who could’ve benefited from this medication. The FDA should be completely gutted and retooled.
  16. Biotech is a bitch.
  17. Patrick Soon-Shiong, Executive Chairman of IBRX, is providing non-convertible debt financing of $30 million while the company sorts this out. It doesn’t sound like we have incoming dilution.
  18. The FDA fucked us
  19. UUUU waking up +.48 to 6.53. Holding 20,000 shares UUUU cost basis 6.19. RVPH 3000 shares GTC order filled at 8.05. Have another GTC order for 3000 more shares at 7.60. Holding 6000 shares of RVPH.
  20. As I posted earlier, I bought IBRX with the expectation of holding it until it reaches three digits or zero and that plan hasn’t changed. The ride ain’t over. Keep the faith
  21. IBRX finishes the day + .87 to 6.41 with 5x the normal volume. IBRX is up over 100% in the last 5 days. We’re bloodied, but not beaten.
  22. Hoping for a partnership with big pharma following FDA approval.
  23. FDA approval should send the stock into the teens. If IBRX announces a good partnership deal with big pharma, it could add to that, but it really depends on the nature of the agreement...ie partnering and distributing vs buying rights to distribute. The more cash it gives IBRX, the better. Then, there are all those other late stage drug trials in the pipeline. And none of this takes into account the possibility that money flow maybe, possibly, finally returns to the bludgeoned biotech sector. When buying stock in IBRX the plan was to ride it to three digits or ride it to 0 and that plan hasn’t changed. IBRX isn’t simply a stonk. It’s a biotech stonk. The risk is sky high and the volatility is madness. Holding 27,800 shares of IBRX at a cost basis of 9.77. Buckle up ‘cause the ride with IBRX ain’t over
×
×
  • Create New...